Umirolimus- versus a sirolimus-eluting stent in patients with coronary artery disease: optical coherence tomographic assessment of lesions

Trial Profile

Umirolimus- versus a sirolimus-eluting stent in patients with coronary artery disease: optical coherence tomographic assessment of lesions

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Feb 2014

At a glance

  • Drugs Umirolimus (Primary) ; Sirolimus
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms SEVEN OCT
  • Most Recent Events

    • 04 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top